Clinical Study

Predictors of Developing Significant Mitral Regurgitation Following Percutaneous Mitral Commissurotomy with Inoue Balloon Technique

Table 1

Baseline Characteristics.

VariableGroup A ( š‘› = 8 8 )Group B ( š‘› = 2 0 )P value

Clinical Characteristics:
(i) Age (Years) 3 1 Ā± 9 3 2 Ā± 1 0 0.86
(ii) Male/Females22/666/140.58
(iii) Height 1 5 9 Ā± 7 1 5 7 Ā± 5 0.81
(iv) BSA 1 . 6 Ā± 0 . 2 1 . 6 Ā± 0 . 3 0.92
(v) Prior PMC13.6%15.8%0.95
(vi) NYHA Class 2 . 6 Ā± 0 . 7 2 . 7 Ā± 0 . 8 0.94
(vii) AF27.2%31.6%0.59

Pre-PMC Echo-Doppler data (except MV Scoring):
(i) MVA (cm2) 0 . 9 Ā± 0 . 2 0 . 8 Ā± 0 . 2 0.37
(ii) MG 1 4 Ā± 3 1 3 Ā± 2 0.71
(iii) SPAP 4 4 Ā± 2 0 4 1 Ā± 2 1 0.67
(iv) LA dimension 4 . 8 Ā± 1 . 0 4 . 9 Ā± 0 . 7 0.47

BSA: body surface area; NYHA: New York Heart Association classification; AF: atrial fibrillation. *Significant at <0.05